Australian (ASX) Stock Market Forum

Coronavirus (COVID-19/SARS-CoV-2) outbreak discussion

Will the "Corona Virus" turn into a worldwide epidemic or fizzle out?

  • Yes

    Votes: 37 49.3%
  • No

    Votes: 9 12.0%
  • Bigger than SARS, but not worldwide epidemic (Black Death/bubonic plague)

    Votes: 25 33.3%
  • Undecided

    Votes: 4 5.3%

  • Total voters
    75
Sorry must have deleted half the post.
Did they identify omicron as the cause of fatalities?
Where did this chart link from?
The detailed data are found here.
An excellent read, however, is from Fraser Nelson at The Spectator, which uses snippets.
On the basis of what's known to date, if you are double vaxxed or previously infected, then severe illness/ hospitalisation is a low probability, and death may be as low as a tenth of what it was under Delta, depending on age.
 
Hot on the heels of Facebook adfmitting in court documents that its Fact Checking is nothing but opinion, it has copped a broadside from the British Medical Journal about its "factChecking" of BMJ articles.
I guess its another case of the US multinationals sticking together.

From WUWT

Open letter from The BMJ to Mark ZuckerbergDear Mark Zuckerberg,We are Fiona Godlee and Kamran Abbasi, editors of The BMJ, one of the world’s oldest and most influential general medical journals. We are writing to raise serious concerns about the “fact checking” being undertaken by third party providers on behalf of Facebook/Meta.In September, a former employee of Ventavia, a contract research company helping carry out the main Pfizer covid-19 vaccine trial, began providing The BMJ with dozens of internal company documents, photos, audio recordings, and emails. These materials revealed a host of poor clinical trial research practices occurring at Ventavia that could impact data integrity and patient safety. We also discovered that, despite receiving a direct complaint about these problems over a year ago, the FDA did not inspect Ventavia’s trial sites.The BMJ commissioned an investigative reporter to write up the story for our journal. The article was published on 2 November, following legal review, external peer review and subject to The BMJ’s usual high level editorial oversight and review.[1]But from November 10, readers began reporting a variety of problems when trying to share our article. Some reported being unable to share it. Many others reported having their posts flagged with a warning about “Missing context … Independent fact-checkers say this information could mislead people.” Those trying to post the article were informed by Facebook that people who repeatedly share “false information” might have their posts moved lower in Facebook’s News Feed. Group administrators where the article was shared received messages from Facebook informing them that such posts were “partly false.”Readers were directed to a “fact check” performed by a Facebook contractor named Lead Stories.[2]We find the “fact check” performed by Lead Stories to be inaccurate, incompetent and irresponsible.— It fails to provide any assertions of fact that The BMJ article got wrong— It has a nonsensical title: “Fact Check: The British Medical Journal Did NOT Reveal Disqualifying And Ignored Reports Of Flaws In Pfizer COVID-19 Vaccine Trials”— The first paragraph inaccurately labels The BMJ a “news blog”— It contains a screenshot of our article with a stamp over it stating “Flaws Reviewed,” despite the Lead Stories article not identifying anything false or untrue in The BMJ article— It published the story on its website under a URL that contains the phrase “hoax-alert”We have contacted Lead Stories, but they refuse to change anything about their article or actions that have led to Facebook flagging our article.We have also contacted Facebook directly, requesting immediate removal of the “fact checking” label and any link to the Lead Stories article, thereby allowing our readers to freely share the article on your platform.There is also a wider concern that we wish to raise. We are aware that The BMJ is not the only high quality information provider to have been affected by the incompetence of Meta’s fact checking regime. To give one other example, we would highlight the treatment by Instagram (also owned by Meta) of Cochrane, the international provider of high quality systematic reviews of the medical evidence.[3] Rather than investing a proportion of Meta’s substantial profits to help ensure the accuracy of medical information shared through social media, you have apparently delegated responsibility to people incompetent in carrying out this crucial task. Fact checking has been a staple of good journalism for decades. What has happened in this instance should be of concern to anyone who values and relies on sources such as The BMJ.
We hope you will act swiftly: specifically to correct the error relating to The BMJ’s article and to review the processes that led to the error; and generally to reconsider your investment in and approach to fact checking overall.
Best wishes,
Fiona Godlee, editor in chief
Kamran Abbasi, incoming editor in chief
The BMJ
Competing interests:
As current and incoming editors in chief, we are responsible for everything The BMJ contains.
References:
[1] Thacker PD. Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial. BMJ. 2021 Nov 2;375:n2635. doi: 10.1136/bmj.n2635. PMID: 34728500. https://www.bmj.com/content/375/bmj.n2635
[2] Miller D. Fact Check: The British Medical Journal Did NOT Reveal Disqualifying And Ignored Reports Of Flaws In Pfizer COVID-19 Vaccine Trials. Nov 10, 2021. https://leadstories.com/hoax-alert/2021/11/fact-check-british-medical-jo…
[3]

Mick
 

The Lancet

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial


Summary​

Background​

Recent evidence indicates a potential therapeutic role of fluvoxamine for COVID-19. In the TOGETHER trial for acutely symptomatic patients with COVID-19, we aimed to assess the efficacy of fluvoxamine versus placebo in preventing hospitalisation defined as either retention in a COVID-19 emergency setting or transfer to a tertiary hospital due to COVID-19.​

Methods​

This placebo-controlled, randomised, adaptive platform trial done among high-risk symptomatic Brazilian adults confirmed positive for SARS-CoV-2 included eligible patients from 11 clinical sites in Brazil with a known risk factor for progression to severe disease. Patients were randomly assigned (1:1) to either fluvoxamine (100 mg twice daily for 10 days) or placebo (or other treatment groups not reported here). The trial team, site staff, and patients were masked to treatment allocation. Our primary outcome was a composite endpoint of hospitalisation defined as either retention in a COVID-19 emergency setting or transfer to tertiary hospital due to COVID-19 up to 28 days post-random assignment on the basis of intention to treat. Modified intention to treat explored patients receiving at least 24 h of treatment before a primary outcome event and per-protocol analysis explored patients with a high level adherence (>80%). We used a Bayesian analytic framework to establish the effects along with probability of success of intervention compared with placebo. The trial is registered at ClinicalTrials.gov (NCT04727424) and is ongoing.​

Findings​

The study team screened 9803 potential participants for this trial. The trial was initiated on June 2, 2020, with the current protocol reporting randomisation to fluvoxamine from Jan 20 to Aug 5, 2021, when the trial arms were stopped for superiority. 741 patients were allocated to fluvoxamine and 756 to placebo. The average age of participants was 50 years (range 18–102 years); 58% were female. The proportion of patients observed in a COVID-19 emergency setting for more than 6 h or transferred to a teritary hospital due to COVID-19 was lower for the fluvoxamine group compared with placebo (79 [11%] of 741 vs 119 [16%] of 756); relative risk [RR] 0·68; 95% Bayesian credible interval [95% BCI]: 0·52–0·88), with a probability of superiority of 99·8% surpassing the prespecified superiority threshold of 97·6% (risk difference 5·0%). Of the composite primary outcome events, 87% were hospitalisations. Findings for the primary outcome were similar for the modified intention-to-treat analysis (RR 0·69, 95% BCI 0·53–0·90) and larger in the per-protocol analysis (RR 0·34, 95% BCI, 0·21–0·54). There were 17 deaths in the fluvoxamine group and 25 deaths in the placebo group in the primary intention-to-treat analysis (odds ratio [OR] 0·68, 95% CI: 0·36–1·27). There was one death in the fluvoxamine group and 12 in the placebo group for the per-protocol population (OR 0·09; 95% CI 0·01–0·47). We found no significant differences in number of treatment emergent adverse events among patients in the fluvoxamine and placebo groups.​

Interpretation​

Treatment with fluvoxamine (100 mg twice daily for 10 days) among high-risk outpatients with early diagnosed COVID-19 reduced the need for hospitalisation defined as retention in a COVID-19 emergency setting or transfer to a tertiary hospital.​


.
 
Very interesting...

How the media has been playing us. Keeping up the 'fear factor'. I think we will see Omicron as our way to get/build up natural/herd immunity and get us out of this mess.


Omicron coverage reveals how the establishment, media keep us scared


In March 2020, a profile of the typical COVID victim emerged from Italy. The average decedent was 80 years old, with approximately three comorbidities, such as heart disease, obesity or diabetes. The young had little to worry about; the survival rate for the vast majority of the population was well over 99 percent.​
That portrait never significantly changed. The early assessments of COVID out of Italy have remained valid through today. And so it will prove with the Omicron variant.​
The data out of South Africa, after five weeks of Omicron spread, suggest that Omicron should be a cause for celebration, not fear. Its symptoms are mild to nonexistent in the majority of the infected, especially the vaccinated; hospitalization rates are over nine times lower than for previous COVID strains; deaths are negligible. That assessment will only be confirmed as the United States and other Western countries gather their own data on Omicron.​
Yet the public health establishment and the media are working overtime to gin up Omicron hysteria. The official response to the Omicron variant provides a case study in the deliberate manufacture of fear.​
More on link below....​


 
Vinay Prasad

Very, very good points. Probably his best summary so far.

The more boosters you get, does it really help? Myocarditis increases, is it worth it for under 40's ?

FDA Vaccine Officials Resign & Now Write Op Eds

A Play-by-Play Summary of Politics & Boosters










.
 
Omicron is more infectious but the UK experience tells us this:
Summary
To assess differences in the risk of hospitalisation between the Omicron variant of concern (1) and the Delta variant, we analysed data from all PCR-confirmed SARS-CoV-2 cases in England with last test specimen dates between 1st and 14th December inclusive.​
... Overall, we find evidence of a reduction in the risk of hospitalisation for Omicron relative to Delta infections, averaging over all cases in the study period.​
... These reductions must be balanced against the larger risk of infection with Omicron, due to the reduction in protection provided by both vaccination and natural infection. A previous infection reduces the risk of any hospitalisation by approximately 50% (Table 2) and the risk of a hospital stay of 1+ days by 61% (95%CI:55-65%) (before adjustments for under ascertainment of reinfections).​
...In broad terms, our estimates suggest that individuals who have received at least 2 vaccine doses remain substantially protected against hospitalisation, even if protection against infection has been largely lost against the Omicron variant (4,5).​

I have only highlighted key findings above as the Summary was lengthy.
Overall the picture for hospitalisations and death from Omicron in the UK appear at nowhere the levels they were for Delta and previous variants of concern. On the flipside, even low percentages can collapse the hospital system if infectivity continues at its present exponential rate in Australia.
 
C0979BD5-9C79-4080-B9DC-3624784592EA.png
Sky News Journo gets reality check
 

You can be a triple vaccinated Australian and not be allowed in to WA. You can get sacked from your job in WA for not being vaccinated. But an unvaccinated French backpacker gets in no problem and the government can't seem to explain why?
 
Our PM has proven to be a donkey throughout the pandemic, with States leading the charge in terms of keeping infections in check prior to Omicron's arrival.
His statement's yesterday attracted some interesting social media attention, over and above MSM. What is a bit perplexing is his so called reliance on medical advice, which is now thrown out the window. The international medical advice is to maintain all the original standards relating to minimising spread and vaccinate as much as possible. As I said in an earlier post today, low hospitalisation rates combined with high infectivity can collapse hospital systems. Emphasising this point is what is now underway in the UK and shown below in the 7-day moving average of hospitalisations:
1640246444594.png


So that's the bad news. The good news to date is that mechanical ventilation numbers are still on the decline, indicating that severe illness is less problematic, but only if you are double vaxxed. I will post a chart next week to show if that situation has changed.
 
WA is just delaying the inevitable. QLd is finding out the slow way, WA even slower...

We are all going to catch Covid-19 one way or another. Part and parcel of living in a global community and a highly infectious virus. That's life.
Yep

Bring.
It.
On.

The healthy, face it.

The vulnerable, protect yourselves.

The pu55ies, man the **** up.
 
We are all going to catch Covid-19 one way or another. Part and parcel of living in a global community and a highly infectious virus. That's life.
Whilst true, the real lesson humans need to learn is that the "global community" bit is the actual weapon of mass destruction when it comes to this sort of thing.

Covid-19 might not wipe us out but in due course something will come along that does and if we haven't put in place suitable measures by that time then we're stuffed.

Sad though it may seem, the idea that someone can be pretty much anywhere on earth within 100 hours just isn't sustainable. :2twocents
 
Dominic Perrottet has woken up on the effects of a totally out of control Omicron infection on NSW.

Dominic Perrottet has finally realised that ‘letting it rip’ comes at too high a cost – for all of us

Anne Davies
Anne_Davies,_L.png



The pro-business premier eased restrictions and ‘opened up’ the NSW economy but staff are ill or isolating while customers are staying at home
5568.jpg

Perhaps NSW premier Dominic Perrottet has sensed the public mood, finally. It’s one of worry. Photograph: Mick Tsikas/AAP
Thu 23 Dec 2021 19.14 AEDT
First published on Thu 23 Dec 2021 19.02 AED


New South Wales’s laissez-faire premier, Dominic Perrottet, has found himself mugged by reality on the cusp of Christmas.
Here are the grim statistics that tell us what is happening in NSW: 5,715 new cases reported on Thursday; 1,500 health workers sick or isolating (leaving the health system even more stressed); rising Covid cases in ICU and nearly 150,000 people a day lining up to get tested.

Yes, some of these are travellers, who are required to be tested by other states. But most are people who worry they have been exposed and are now wondering whether they should attend Christmas Day with parents or grandparents.

In the three weeks since the Omicron variant was first detected here on 28 November, Perrottet has been telling us to go out and spend, head to the pub, get back to normal.

 
Dominic Perrottet has woken up on the effects of a totally out of control Omicron infection on NSW.

Dominic Perrottet has finally realised that ‘letting it rip’ comes at too high a cost – for all of us

Anne Davies
View attachment 134712


The pro-business premier eased restrictions and ‘opened up’ the NSW economy but staff are ill or isolating while customers are staying at home
View attachment 134713
Perhaps NSW premier Dominic Perrottet has sensed the public mood, finally. It’s one of worry. Photograph: Mick Tsikas/AAP
Thu 23 Dec 2021 19.14 AEDT
First published on Thu 23 Dec 2021 19.02 AED


New South Wales’s laissez-faire premier, Dominic Perrottet, has found himself mugged by reality on the cusp of Christmas.
Here are the grim statistics that tell us what is happening in NSW: 5,715 new cases reported on Thursday; 1,500 health workers sick or isolating (leaving the health system even more stressed); rising Covid cases in ICU and nearly 150,000 people a day lining up to get tested.

Yes, some of these are travellers, who are required to be tested by other states. But most are people who worry they have been exposed and are now wondering whether they should attend Christmas Day with parents or grandparents.

In the three weeks since the Omicron variant was first detected here on 28 November, Perrottet has been telling us to go out and spend, head to the pub, get back to normal.


And as unvaxed people were still restricted for most of this time, all of this happened in those who are vaccinated
 
Top